The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Heteroresistance: A cause of unexplained antibiotic treatment failure?
Open accessAbstract
Antibiotic resistance is a major and increasing healthcare problem that threatens many of the achievements of modern medicine.Transplants, chemotherapy, and survival of extremely premature infants all rely on the efficacy of antibiotics to fight off infection.According to the Centers for Disease Control and Prevention (CDC), over 2 million infections every year in the United States are caused by antibiotic-resistant bacteria, resulting in at least 23,000 deaths and US$55 billion in increased healthcare costs and lost productivity [1].Without significant action, antibiotic-resistant infections could annually kill 10 million people worldwide by the year 2050, eclipsing the number of deaths caused by cancer and adding US$100 trillion to the world's healthcare costs by that time [2].It is therefore critical to understand novel and often underrecognized mechanisms of resistance that represent barriers to antibiotic efficacy so as to combat them with new drugs and therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial heteroresistance: An emerging field in need of clarity
El-Halfawy, O. M., & Valvano, M. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-14 · Cited by 489
Phenotypic Resistance to Antibiotics
Corona, F., & Martinez, J. (2013) · Antibiotics · doi:10.3390/antibiotics2020237 · Cited by 205
Ferreira, G. F., Santos, J. R. A., Costa, M. C. D., Holanda, R. A. D., Denadai, Â. M. L., Freitas, G. J. C. D., Santos, Á. R. C., Tavares, P. B., Paixão, T. A., & Santos, D. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00466-15 · Cited by 44
Mutants with heteroresistance to amphotericin B and fluconazole in Candida
Claudino, A. L. R., Peixoto Junior, R. F., Melhem, M. S. C., Szeszs, M. W., Lyon, J. P., Chavasco, J. K., & Franco, M. C. (2009) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822009000400028 · Cited by 12
Cited by
The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance
Kowalska-Krochmal, B., & Dudek-Wicher, R. (2021) · Pathogens · doi:10.3390/pathogens10020165 · Cited by 1,039
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Dartois, V. A., & Rubin, E. J. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00731-y · Cited by 490
Zhai, B., Liao, C., Jaggavarapu, S., Tang, Y., Rolling, T., Ning, Y., Sun, T., Bergin, S. A., Gjonbalaj, M., Miranda, E., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03183-4 · Cited by 62
Self-citationTian, Y., Zhang, Q., Wen, L., & Chen, J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00152-21 · Cited by 62
Kon, H., Hameir, A., Nutman, A., Temkin, E., Keren Paz, A., Lellouche, J., Schwartz, D., Weiss, D. S., Kaye, K. S., Daikos, G. L., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05093-22 · Cited by 35
Self-citation
Metadata
- Authors
- Band, V. I., & Weiss, D. S.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-06-06
- Volume
- 15
- Issue
- 6
- Pages
- e1007726
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2968720570
- Cited by
- 212
- References
- 4
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Heteroresistance: A cause of unexplained antibiotic treatment failure? https://app.cochat.ai/papers/10.1371/journal.ppat.1007726
- The paper
- Band, V. I., & Weiss, D. S. (2019). Heteroresistance: A cause of unexplained antibiotic treatment failure? PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1007726
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.